InvestorsHub Logo
icon url

Rentier

09/10/13 8:42 PM

#1815 RE: NYCJR #1814

True, but 400 market cap for TTNP puts stock price at about $5 share. Also Vanda's drug isn't even approved yet and it's 52 week high is $13.30 today it went up again to $11.99.

How high it can go and duration to get there is also dependent on what other applications and indications Titan/Braeburn can go for, for example pain and another would be using Proneura for other drugs.

I felt very guarded to after getting initially burned by Vanda and then making a good mint on it once they got Fanapt approved.

The biggest issues right now are:

1. getting Probuphine approved, but they look to be heading in right direction. Braeburn hired FDA consultant, Dr. Young which is same route VNDA did to get Fanapt approved 2nd time around.

2. not listed on major exchange so can't bring in all the big money investments yet, they are going to get listed once approved.